Semaglutide

GLP-1 receptor agonist

Semaglutide is a GLP-1 receptor agonist used in prescription care for diabetes and chronic weight management. PeptideStack treats it as a tracking hub for appetite, GI symptoms, nutrition, body-composition change, and visible side effects.

OzempicWegovyRybelsus

What It Is

Mechanism: GLP-1 signaling supports glucose regulation, slows gastric emptying, and affects appetite and satiety pathways.

Research Areas

Weight-management research

Strong human evidence

Weeks to months

Glucose-control context

Strong human evidence

Weeks

Side-effect tracking

Clinically recognized

First weeks and titration windows

Evidence Context

Top labels, trials, papers, and regulatory sources tied to Semaglutide. This is research context, not treatment advice.

1 sources

PubMed2021

Once-weekly semaglutide in adults with overweight or obesity

STEP 1 was a large randomized trial of once-weekly semaglutide 2.4 mg plus lifestyle intervention in adults with overweight or obesity.

Weight-management efficacy contextRandomized controlled trial1961 participantsNew England Journal of Medicine33567185

What to track first

The useful job is not making semaglutide recommendations. It is helping users see how timing, meals, hydration, symptoms, sleep, hair, and skin notes change together.

• Log GI symptoms, appetite, protein intake, hydration, and constipation risk alongside the prescribed schedule.

• Track rapid weight change with strength, recovery, hair shedding, and skin-quality notes.

• Separate clinician-directed medication changes from lifestyle and support-stack changes so patterns stay readable.

Nausea and GI discomfort

Common in clinical labelingMild to moderate

Often most visible around initiation or schedule changes.

Constipation or diarrhea

Clinically recognizedVariable

Best tracked with meals, hydration, and fiber changes.

Hair and skin complaints

Reported by users during rapid lossVariable

Can be confounded by nutrition, stress, and rate of weight change.

Research Status

Prescription medication with substantial human clinical evidence for indicated uses.

Stack Context

GI and hydration context

Track fluids, electrolytes, fiber, bowel changes, and symptom timing.

Body-composition context

Track protein, strength, recovery, skin notes, and hair shedding during loss phases.

Warnings

• Prescription GLP-1 decisions should stay with a qualified healthcare provider.

• PeptideStack does not suggest medication changes, escalation, or substitution.

• Severe abdominal pain, persistent vomiting, dehydration, or allergic symptoms need medical care.

Start Tracking

Track semaglutide timing, symptoms, appetite, nutrition, sleep, and visible changes in PeptideStack.

Use PeptideStack to organize the lived pattern around a clinician-directed plan: symptoms, meals, training, sleep, visible changes, and support layers.

Open App Funnel View Tools